Drug profile

The FDA adverse-event record for Not Provided

16 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Not Provided. See the species affected, top reactions, and outcomes below.

16
adverse-event reports
12.5%
death-coded share
Dog
most-reported species
6
Other abnormal test result NOS - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
16
Total Reports
2
Deaths Reported
12.5%
Death Rate

Active Ingredients

Not Provided

Administration Routes

UnknownOralTopicalIntravenous

Species Affected

Dog 14
Cat 2

Most Affected Breeds

Retriever - Labrador 5
Poodle - Toy 2
Terrier - Yorkshire 2
Domestic (unspecified) 2
Shih Tzu 1
Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog) 1
Spitz - German Pomeranian 1
Terrier - Jack Russell 1
Pekingese 1

Most Reported Reactions

Other abnormal test result NOS 6
Elevated serum alkaline phosphatase (SAP) 4
Elevated alanine aminotransferase (ALT) 3
Proteinuria 3
Skin inflammation NOS 3
Palpable mass NOS 3
Skin lesion NOS 3
Surgical site disorder 3
Pyoderma 2
Death 2
Lack of efficacy (ectoparasite) - flea 2
Thrombocytosis 1

Outcome Breakdown

Outcome Unknown
8 (50.0%)
Recovered/Normal
3 (18.8%)
Ongoing
3 (18.8%)
Died
2 (12.5%)

Not Provided Adverse Event Insights

16 reports name Not Provided; 2 recorded a death outcome (12.5% of reported events, not a population-level mortality rate). Active ingredient: Not Provided. Administration routes: Unknown, Oral, Topical, Intravenous.

By species: Dog (14 reports), Cat (2 reports). By breed: Retriever - Labrador (5), Poodle - Toy (2), Terrier - Yorkshire (2).

Leading clinical signs: Other abnormal test result NOS (6), Elevated serum alkaline phosphatase (SAP) (4), Elevated alanine aminotransferase (ALT) (3), Proteinuria (3). Outcome, 16 coded reports: Outcome Unknown leads at 50.0%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.